Clinical Trials Browser

INDUSTRY × Malignant Solid Tumour × avelumab × Clear all

NCT02923466 2022-04-27

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour